194 related articles for article (PubMed ID: 21680732)
21. Giant cadherins Fat and Dachsous self-bend to organize properly spaced intercellular junctions.
Tsukasaki Y; Miyazaki N; Matsumoto A; Nagae S; Yonemura S; Tanoue T; Iwasaki K; Takeichi M
Proc Natl Acad Sci U S A; 2014 Nov; 111(45):16011-6. PubMed ID: 25355906
[TBL] [Abstract][Full Text] [Related]
22. Keratinocytes negatively regulate the N-cadherin levels of melanoma cells via contact-mediated calcium regulation.
Chung H; Jung H; Jho EH; Multhaupt HAB; Couchman JR; Oh ES
Biochem Biophys Res Commun; 2018 Sep; 503(2):615-620. PubMed ID: 29902459
[TBL] [Abstract][Full Text] [Related]
23. Sleeping giants: emerging roles for the fat cadherins in health and disease.
Sadeqzadeh E; de Bock CE; Thorne RF
Med Res Rev; 2014 Jan; 34(1):190-221. PubMed ID: 23720094
[TBL] [Abstract][Full Text] [Related]
24. Fat and Dachsous cadherins in mammalian development.
Kasiah J; McNeill H
Curr Top Dev Biol; 2023; 154():223-244. PubMed ID: 37100519
[TBL] [Abstract][Full Text] [Related]
25. Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression.
Hsu M; Andl T; Li G; Meinkoth JL; Herlyn M
J Cell Sci; 2000 May; 113 ( Pt 9)():1535-42. PubMed ID: 10751145
[TBL] [Abstract][Full Text] [Related]
26. Regulation and function of the atypical cadherin FAT1 in hepatocellular carcinoma.
Valletta D; Czech B; Spruss T; Ikenberg K; Wild P; Hartmann A; Weiss TS; Oefner PJ; Müller M; Bosserhoff AK; Hellerbrand C
Carcinogenesis; 2014 Jun; 35(6):1407-15. PubMed ID: 24590895
[TBL] [Abstract][Full Text] [Related]
27. FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells.
Dikshit B; Irshad K; Madan E; Aggarwal N; Sarkar C; Chandra PS; Gupta DK; Chattopadhyay P; Sinha S; Chosdol K
Oncogene; 2013 Aug; 32(33):3798-808. PubMed ID: 22986533
[TBL] [Abstract][Full Text] [Related]
28. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development.
Robert G; Gaggioli C; Bailet O; Chavey C; Abbe P; Aberdam E; Sabatié E; Cano A; Garcia de Herreros A; Ballotti R; Tartare-Deckert S
Cancer Res; 2006 Aug; 66(15):7516-23. PubMed ID: 16885349
[TBL] [Abstract][Full Text] [Related]
29. FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer.
Hu X; Zhai Y; Kong P; Cui H; Yan T; Yang J; Qian Y; Ma Y; Wang F; Li H; Cheng C; Zhang L; Jia Z; Li Y; Yang B; Xu E; Wang J; Yang J; Bi Y; Chang L; Wang Y; Zhang Y; Song B; Li G; Shi R; Liu J; Zhang M; Cheng X; Cui Y
Cancer Lett; 2017 Jul; 397():83-93. PubMed ID: 28366557
[TBL] [Abstract][Full Text] [Related]
30. Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation.
Morris LG; Kaufman AM; Gong Y; Ramaswami D; Walsh LA; Turcan Ş; Eng S; Kannan K; Zou Y; Peng L; Banuchi VE; Paty P; Zeng Z; Vakiani E; Solit D; Singh B; Ganly I; Liau L; Cloughesy TC; Mischel PS; Mellinghoff IK; Chan TA
Nat Genet; 2013 Mar; 45(3):253-61. PubMed ID: 23354438
[TBL] [Abstract][Full Text] [Related]
31. Mammalian Fat1 cadherin regulates actin dynamics and cell-cell contact.
Tanoue T; Takeichi M
J Cell Biol; 2004 May; 165(4):517-28. PubMed ID: 15148305
[TBL] [Abstract][Full Text] [Related]
32. Surface expression of precursor N-cadherin promotes tumor cell invasion.
Maret D; Gruzglin E; Sadr MS; Siu V; Shan W; Koch AW; Seidah NG; Del Maestro RF; Colman DR
Neoplasia; 2010 Dec; 12(12):1066-80. PubMed ID: 21170270
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development.
Li G; Schaider H; Satyamoorthy K; Hanakawa Y; Hashimoto K; Herlyn M
Oncogene; 2001 Dec; 20(56):8125-35. PubMed ID: 11781826
[TBL] [Abstract][Full Text] [Related]
34. Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway.
Li Z; Razavi P; Li Q; Toy W; Liu B; Ping C; Hsieh W; Sanchez-Vega F; Brown DN; Da Cruz Paula AF; Morris L; Selenica P; Eichenberger E; Shen R; Schultz N; Rosen N; Scaltriti M; Brogi E; Baselga J; Reis-Filho JS; Chandarlapaty S
Cancer Cell; 2018 Dec; 34(6):893-905.e8. PubMed ID: 30537512
[TBL] [Abstract][Full Text] [Related]
35. Collagen XVII is expressed in malignant but not in benign melanocytic tumors and it can mediate antibody induced melanoma apoptosis.
Krenacs T; Kiszner G; Stelkovics E; Balla P; Teleki I; Nemeth I; Varga E; Korom I; Barbai T; Plotar V; Timar J; Raso E
Histochem Cell Biol; 2012 Oct; 138(4):653-67. PubMed ID: 22688676
[TBL] [Abstract][Full Text] [Related]
36. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression.
Krengel S; Grotelüschen F; Bartsch S; Tronnier M
J Cutan Pathol; 2004 Jan; 31(1):1-7. PubMed ID: 14675278
[TBL] [Abstract][Full Text] [Related]
37. New insights into Fat cadherins.
Tanoue T; Takeichi M
J Cell Sci; 2005 Jun; 118(Pt 11):2347-53. PubMed ID: 15923647
[TBL] [Abstract][Full Text] [Related]
38. Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis.
Sutton SK; Cheung BB; Massudi H; Tan O; Koach J; Mayoh C; Carter DR; Marshall GM
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2241-2250. PubMed ID: 31342168
[TBL] [Abstract][Full Text] [Related]
39. Fat1 suppresses the tumor-initiating ability of nonsmall cell lung cancer cells by promoting Yes-associated protein 1 nuclear-cytoplasmic translocation.
Li M; Zhong Y; Wang M
Environ Toxicol; 2021 Nov; 36(11):2333-2341. PubMed ID: 34390292
[TBL] [Abstract][Full Text] [Related]
40. Status of RASSF1A in uveal melanocytes and melanoma cells.
Calipel A; Abonnet V; Nicole O; Mascarelli F; Coupland SE; Damato B; Mouriaux F
Mol Cancer Res; 2011 Sep; 9(9):1187-98. PubMed ID: 21788308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
